Fox Christine Ann

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 15% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Fox Christine Ann's trades of Mereo BioPharma Group PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-16 2024-09-13
S Sale
6,587 +27.2%
379.96
US$3,612,096 		6,587 +27.2% 379.96 US$3,612,096
2024-09-16 2024-09-12
S Sale
18,692 -1.1%
91.29
US$4,096,906 		18,692 -1.1% 91.29 US$4,096,906
2024-09-12 2024-09-12
PrS Proposed sale
90,596
257.31
US$3,348,366 		90,596 257.31 US$3,348,366
2024-06-27 2024-06-26
S Sale
29,439 -33.8%
3.39
US$99,892 		29,439 -33.8% 3.39 US$99,892
2024-06-27 2024-06-25
S Sale
12,990 -13.0%
3.69
US$47,984 		12,990 -13.0% 3.69 US$47,984
2024-06-24 2024-06-25
PrS Proposed sale
46,672
3.98
US$185,755 		46,672 3.98 US$185,755
2024-06-20 2024-06-21
PrS Proposed sale
46,672
3.98
US$185,755 		46,672 3.98 US$185,755